These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30521789)

  • 1. Comparison of electroencephalogram (EEG) response to MDPV versus the hallucinogenic drugs MK-801 and ketamine in rats.
    Shokry IM; Sinha V; Da Silva G; Park SB; Callanan JJ; Tao R
    Exp Neurol; 2019 Mar; 313():26-36. PubMed ID: 30521789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.
    Baumann MH; Partilla JS; Lehner KR; Thorndike EB; Hoffman AF; Holy M; Rothman RB; Goldberg SR; Lupica CR; Sitte HH; Brandt SD; Tella SR; Cozzi NV; Schindler CW
    Neuropsychopharmacology; 2013 Mar; 38(4):552-62. PubMed ID: 23072836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of 3,4-methylenedioxypyrovalerone discrimination in female Sprague-Dawley rats.
    Thomas AM; Cargile KJ; Lunn JA; Baker LE
    Behav Pharmacol; 2021 Sep; 32(6):524-532. PubMed ID: 34397448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
    Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
    Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) and structurally related synthetic cathinones.
    Seaman RW; Doyle MR; Sulima A; Rice KC; Collins GT
    Behav Pharmacol; 2021 Aug; 32(5):357-367. PubMed ID: 33587482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated exposure to 3,4-methylenedioxypyrovalerone and cocaine produces locomotor sensitization with minimal effects on brain monoamines.
    Kohler RJ; Perrine SA; Baker LE
    Neuropharmacology; 2018 May; 134(Pt A):22-27. PubMed ID: 29042316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters.
    Magee CP; German CL; Siripathane YH; Curtis PS; Anderson DJ; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2020 Aug; 374(2):273-282. PubMed ID: 32385092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional connectivity, behavioral and dopaminergic alterations 24 hours following acute exposure to synthetic bath salt drug methylenedioxypyrovalerone.
    Colon-Perez LM; Pino JA; Saha K; Pompilus M; Kaplitz S; Choudhury N; Jagnarine DA; Geste JR; Levin BA; Wilks I; Setlow B; Bruijnzeel AW; Khoshbouei H; Torres GE; Febo M
    Neuropharmacology; 2018 Jul; 137():178-193. PubMed ID: 29729891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.
    Baumann MH; Bukhari MO; Lehner KR; Anizan S; Rice KC; Concheiro M; Huestis MA
    Curr Top Behav Neurosci; 2017; 32():93-117. PubMed ID: 27830575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic Effects of Major Bath Salt Constituents 3,4-Methylenedioxypyrovalerone (MDPV), Mephedrone, and Methylone Are Enhanced Following Co-exposure.
    Allen SA; Tran LH; Oakes HV; Brown RW; Pond BB
    Neurotox Res; 2019 Jul; 36(1):132-143. PubMed ID: 30879275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of MDPV on dopamine transporter regulation in male rats. Comparison with cocaine.
    Lopez-Arnau R; Duart-Castells L; Aster B; Camarasa J; Escubedo E; Pubill D
    Psychopharmacology (Berl); 2019 Mar; 236(3):925-938. PubMed ID: 30284596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of monoaminergic mechanisms to the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) in Sprague-Dawley rats.
    Risca HI; Baker LE
    Psychopharmacology (Berl); 2019 Mar; 236(3):963-971. PubMed ID: 30554256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic neurobehavioral effects of the designer drug and bath salt constituent 3,4-methylenedioxypyrovalerone in the rat.
    Atehortua-Martinez LA; Masniere C; Campolongo P; Chasseigneaux S; Callebert J; Zwergel C; Mai A; Laplanche JL; Chen H; Etheve-Quelquejeu M; Mégarbane B; Benturquia N
    J Psychopharmacol; 2019 Mar; 33(3):392-405. PubMed ID: 30644332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).
    Watterson LR; Kufahl PR; Nemirovsky NE; Sewalia K; Grabenauer M; Thomas BF; Marusich JA; Wegner S; Olive MF
    Addict Biol; 2014 Mar; 19(2):165-74. PubMed ID: 22784198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
    Anneken JH; Angoa-Pérez M; Kuhn DM
    J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects.
    Anizan S; Concheiro M; Lehner KR; Bukhari MO; Suzuki M; Rice KC; Baumann MH; Huestis MA
    Addict Biol; 2016 Mar; 21(2):339-47. PubMed ID: 25475011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats.
    Schindler CW; Thorndike EB; Goldberg SR; Lehner KR; Cozzi NV; Brandt SD; Baumann MH
    Psychopharmacology (Berl); 2016 May; 233(10):1981-90. PubMed ID: 26319160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity.
    Colon-Perez LM; Tran K; Thompson K; Pace MC; Blum K; Goldberger BA; Gold MS; Bruijnzeel AW; Setlow B; Febo M
    Neuropsychopharmacology; 2016 Aug; 41(9):2352-65. PubMed ID: 26997298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-conserved residues dictate dopamine transporter selectivity for the potent synthetic cathinone and psychostimulant MDPV.
    Steele TWE; Spires Z; Jones CB; Glennon RA; Dukat M; Eltit JM
    Neuropharmacology; 2021 Dec; 200():108820. PubMed ID: 34619165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats.
    Kolanos R; Partilla JS; Baumann MH; Hutsell BA; Banks ML; Negus SS; Glennon RA
    ACS Chem Neurosci; 2015 May; 6(5):771-7. PubMed ID: 25688761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.